Petrochemicals

News

Modest and Fragile Recovery: Interview with Dr. Hubert Mandery, Cefic

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Petrochemicals

Exxon Says Still Working On Qatar Ras Laffan Project

Exxon Quits New $6 Billion Ras Laffan Petchem Project

Ineos Confirms Continuation of Strong Trading Conditions in Q2 2010

Downstream Oil Construction Costs Continue to Rise

Portugal Strike To Halt Galp Refineries April 19-21

Aramco, Dow to Move Petchem Plant to Jubail

Saudi Sabic-Japan JV Starts Output at Expanded Unit

Reliance Leases 1.2 Million Barrels of Storage in Bahamas

European Oil Refineries Sold And Up For Sale

Braskem: No Immediate Plans for Sunoco's Largest Plant

Braskem Acquires Sunoco Chemicals in the U.S.

Shell Sells Stake in Three Nigerian Oil Licenses

$370 Million Petrochemical Investment

Modest and Fragile Recovery: Interview with Dr. Hubert Mandery, Cefic

Top-Feature

Upcoming Virtual Events

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Siemens Joins the Global Impact Coalition

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

ADCs for Precision Cancer Therapy

Petrochemicals

Top-Feature

Upcoming Virtual Events

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Siemens Joins the Global Impact Coalition

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

Newsletter & e-edition